2023
Tumor-Na茂ve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials
JCO Precision Oncology
Research at a glance
Research activity
My publications
Filter publications
29 publications
2022
A risk stratification model for toxicities in phase 1 immunotherapy trials
European Journal of Cancer
2022
Assessing Oncologists鈥� Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil
JTO Clinical and Research Reports
鈥�2022
Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials
European Journal of Cancer
2022
Patient-centered trials in oncology: Time for a change
Med